READ MORE ABOUT

 
Please reload

BIOFORTIS AGENDA

July 18, 2018

Despite significant progress in anti-cancer treatment such as immunotherapy, chemotherapy remains a gold standard. Pemetrexed is a chemotherapeutic agent commonly used in lung cancer. This drug has a...

June 5, 2018

The microbiome field is currently at the beginning of the third wave with ongoing development of therapeutic solutions, an increasing number of products in clinical phases, and the creation of several...

May 22, 2018

Following our three first chapters on “The human microbiome: a promising research area with multiple applications”, this article is comparing the emergence of the human microbiome field with the rise...

April 18, 2018

Interview de Fatiha Serbouti, athlète nantaise, passionnée de course à pied et gérante de la boutique Serbouti Sport spécialisée en running, trail et triathlon. Dans sa boutique spécialisée ouverte à...

November 30, 2017

To better define the Irritable Bowel Syndrome and highlight its importance discover our latest infographics:

November 21, 2017

With 300 participants and close to 60 posters presented, this event was quite a success! In order to highlight Microbiota 2017 recent advances & perspectives, it was relevant to interview Hervé Blotti...

Please reload

MICROBIOTA CASE STUDY

FOLLOW US

  • LinkedIn Biofortis Mérieux NutriSc.
  • Twitter Biofortis Mérieux NutriSc.
  • YouTube Biofortis Mérieux NutriSc.

SUBSCRIBE 

© 2017 Biofortis Mérieux NutriSciences

ABOUT BIOFORTIS

As part of Mérieux NutriSciences, Biofortis supports the food and health industries by conducting research projects with a unique nutrition and analytical service. A one-stop shop CRO offering innovative services including clinical assessments, microbiota-related research, sensory evaluation and consumer studies.

FIND US ON

  • LinkedIn Biofortis Mérieux NutriSc.
  • Twitter Biofortis Mérieux NutriSc.
  • YouTube Biofortis Mérieux NutriSc.

3 Route de la Chatterie

44800 Saint-Herblain

FRANCE

Tel: +33 2 40 20 57 99